|Denaro||109,80 x 800|
|Lettera||112,00 x 1300|
|Min-Max giorno||109,73 - 111,99|
|Intervallo di 52 settimane||86,16 - 128,54|
|Beta (5 anni mensile)||0,68|
|Rapporto PE (ttm)||34,98|
|Prossima data utili||14 lug 2021 - 19 lug 2021|
|Rendimento e dividendo (forward)||1,80 (1,64%)|
|Data ex dividendo||14 lug 2021|
|Stima target 1A||125,81|
The Illinois-based medical devices and health care company Abbott Laboratories’ shares slumped about 8% on Tuesday after the company slashed its full-year 2021 profit outlook due to significantly lower recent and projected COVID-19 diagnostic testing demand.
For decades, income-minded investors have searched for the best dividend stocks out there.
Illinois-based medical devices and health care company Abbott Laboratories’ shares fell over 3% on Tuesday after the company missed earnings and revenue estimates for the first quarter.